Moderna’s Vaccine News “Encouraging” But Won’t Solve Immediate Problem of Virus Surge in Europe & Americas – WHO 16/11/2020 Kerry Cullinan The World Health Organization is encouraged by early results of the efficacy of the Moderna COVID-19 vaccine but its most immediate concern is the impact of the surge in cases in Europe and the Americas, threatening both health workers and health systems. “While we continue to receive encouraging news about COVID-19 vaccines and remain cautiously […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Digital Diagnoses And Medical Records – Geneva Health Forum’s Virtual Innovation Fair Showcases Low-Cost Health Technologies 15/11/2020 Svĕt Lustig Vijay Third in a series – Even before the coronavirus struck, large swathes of Africa, as well as parts of South-East Asia and Latin America, still relied on fragmented paper-based medical records, making it difficult to track people’s medical history – and thus provide high-quality treatment and care. The Virtual Innovation Fair, which is a key […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> WHO Funding Inequalities Drive African Calls For Change At World Health Assembly 11/11/2020 Paul Adepoju & Elaine Ruth Fletcher Despite nearly two years of internal restructuring, WHO’s budget at its Geneva headquarters is still twice the amount spent in all 54 countries of the Organization’s African Region, said the African bloc of stated at Wednesday’s World Health Assembly. Speaking on behalf of the African bloc, Seychelles noted that the most recent WHO financial report […] Continue reading -> Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> COVID-19 Vaccine Breakthrough: Interim Results From Pfizer Candidate Show It Prevented 90% Of Cases 09/11/2020 J Hacker & Madeleine Hoecklin A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading -> WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Digital Diagnoses And Medical Records – Geneva Health Forum’s Virtual Innovation Fair Showcases Low-Cost Health Technologies 15/11/2020 Svĕt Lustig Vijay Third in a series – Even before the coronavirus struck, large swathes of Africa, as well as parts of South-East Asia and Latin America, still relied on fragmented paper-based medical records, making it difficult to track people’s medical history – and thus provide high-quality treatment and care. The Virtual Innovation Fair, which is a key […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> WHO Funding Inequalities Drive African Calls For Change At World Health Assembly 11/11/2020 Paul Adepoju & Elaine Ruth Fletcher Despite nearly two years of internal restructuring, WHO’s budget at its Geneva headquarters is still twice the amount spent in all 54 countries of the Organization’s African Region, said the African bloc of stated at Wednesday’s World Health Assembly. Speaking on behalf of the African bloc, Seychelles noted that the most recent WHO financial report […] Continue reading -> Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> COVID-19 Vaccine Breakthrough: Interim Results From Pfizer Candidate Show It Prevented 90% Of Cases 09/11/2020 J Hacker & Madeleine Hoecklin A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading -> WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Digital Diagnoses And Medical Records – Geneva Health Forum’s Virtual Innovation Fair Showcases Low-Cost Health Technologies 15/11/2020 Svĕt Lustig Vijay Third in a series – Even before the coronavirus struck, large swathes of Africa, as well as parts of South-East Asia and Latin America, still relied on fragmented paper-based medical records, making it difficult to track people’s medical history – and thus provide high-quality treatment and care. The Virtual Innovation Fair, which is a key […] Continue reading -> WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> WHO Funding Inequalities Drive African Calls For Change At World Health Assembly 11/11/2020 Paul Adepoju & Elaine Ruth Fletcher Despite nearly two years of internal restructuring, WHO’s budget at its Geneva headquarters is still twice the amount spent in all 54 countries of the Organization’s African Region, said the African bloc of stated at Wednesday’s World Health Assembly. Speaking on behalf of the African bloc, Seychelles noted that the most recent WHO financial report […] Continue reading -> Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> COVID-19 Vaccine Breakthrough: Interim Results From Pfizer Candidate Show It Prevented 90% Of Cases 09/11/2020 J Hacker & Madeleine Hoecklin A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading -> WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Proposes Swiss-Based Global Repository For Sharing Biological Samples Related To Disease Outbreak Threats 13/11/2020 Menaka Rao & Elaine Ruth Fletcher BREAKING – World Health Organization Director-General, Dr Tedros Adhanom Ghebreyesus has proposed the creation of a Swiss-based global repository for sharing pathogen materials and clinical samples related to potential outbreak threats – allowing for the more rapid development of medical interventions. The COVID-19 pandemic has shown the urgent need for this kind of system, said […] Continue reading -> WHO Funding Inequalities Drive African Calls For Change At World Health Assembly 11/11/2020 Paul Adepoju & Elaine Ruth Fletcher Despite nearly two years of internal restructuring, WHO’s budget at its Geneva headquarters is still twice the amount spent in all 54 countries of the Organization’s African Region, said the African bloc of stated at Wednesday’s World Health Assembly. Speaking on behalf of the African bloc, Seychelles noted that the most recent WHO financial report […] Continue reading -> Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> COVID-19 Vaccine Breakthrough: Interim Results From Pfizer Candidate Show It Prevented 90% Of Cases 09/11/2020 J Hacker & Madeleine Hoecklin A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading -> WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Funding Inequalities Drive African Calls For Change At World Health Assembly 11/11/2020 Paul Adepoju & Elaine Ruth Fletcher Despite nearly two years of internal restructuring, WHO’s budget at its Geneva headquarters is still twice the amount spent in all 54 countries of the Organization’s African Region, said the African bloc of stated at Wednesday’s World Health Assembly. Speaking on behalf of the African bloc, Seychelles noted that the most recent WHO financial report […] Continue reading -> Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> COVID-19 Vaccine Breakthrough: Interim Results From Pfizer Candidate Show It Prevented 90% Of Cases 09/11/2020 J Hacker & Madeleine Hoecklin A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading -> WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Norway Ramps Up Efforts Against Non-Communicable Diseases in Low-income Countries 11/11/2020 Raisa Santos Norway will contribute an additional 133 million USD (1.2 billion NOK) to reduce the burden of non-communicable diseases (NCDs) in low-income countries from 2020 to 2024, the Ministry of International Development announced today. The announcement comes in the wake of last year’s path-blazing strategy for how to tackle the growing NCD burden in LMICs, “Better […] Continue reading -> COVID-19 Vaccine Breakthrough: Interim Results From Pfizer Candidate Show It Prevented 90% Of Cases 09/11/2020 J Hacker & Madeleine Hoecklin A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading -> WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Vaccine Breakthrough: Interim Results From Pfizer Candidate Show It Prevented 90% Of Cases 09/11/2020 J Hacker & Madeleine Hoecklin A COVID-19 vaccine candidate developed by Pfizer and BioNTech has far exceeded expectations, showing a 90% efficacy rate so far among the tens of thousands of volunteers who were immunized in a clinical trial, the company said on Monday. “Today is a great day for science and humanity. The first set of results from our […] Continue reading -> WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Seeks To Allay Fears About Threat To Vaccine R&D From COVID-19 Virus Mutation Found Among Mink 06/11/2020 J Hacker & Elaine Ruth Fletcher There is so far no evidence that the outbreak of mutant SARS-CoV-2 virus strains exploding in Danish mink farms threaten the development of a successful COVID-19 vaccine, said top World Health Organization (WHO) officials on Friday. More than 200 mink farms in Denmark have reported cases of SARS-CoV-2 infections, prompting Denmark’s prime minister, Mette Frederiksen, […] Continue reading -> Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Distributing Future COVID-19 Vaccines Equitably Could Prevent 60% Of Deaths 05/11/2020 Editorial team Rather than hoarding vaccine supplies, rich countries that ensure global access to a new COVID-19 vaccine will pave the way to a larger reduction in pandemic related deaths worldwide, according to a new model developed by the Boston-based Northeastern University. Their findings reinforce the argument the World Health Organization and other global health leaders that […] Continue reading -> Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Regeneron and Eli Lilly Pause Antibody Cocktail Trials On Hospitalzed Patients; Moderna Preps for Global Vaccine Launch 02/11/2020 Madeleine Hoecklin Regeneron Pharmaceuticals suspended enrollment of critically ill and hospitalized patients in its COVID-19 antibody cocktail treatment clinical trial on Friday, due to what it said was a safety concern. The pharma company’s independent data monitoring committee (IDMC) recommended this pause “based on a potential safety signal and an unfavorable risk/benefit profile,” advising on the collection […] Continue reading -> Posts navigation Older postsNewer posts